Evidence map›Paper›PMID 38404578›Full record

ArticleFrontiers in immunology2024

Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy.

Jin Wang, Yu Cheng, Yulin Wang, Hengxin Liu, Shuang Wu, Guangwei Tian, Jinglei Qu, Xiujuan Qu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jin WangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Yu ChengDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Yulin WangDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Hengxin LiuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Shuang WuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Guangwei TianDepartment of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China.
Jinglei QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
Xiujuan QuDepartment of Medical Oncology, The First Hospital of China Medical University, Shenyang, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymph node (LN) metastasis is a common mode of metastasis in advanced gastric cancer (GC), while axillary LN metastasis infrequently occurs in GC. There are few reports on this rare type of metastasis - especially its clinicopathological features - and systemic treatment are unclear. We describe a case of GC with extensive metastasis, including the rare axillary LN metastasis. The patient achieved partial response of optimal efficacy, who was treated with combination immunotherapy as second-line treatment for nearly two years. The potential mechanisms were revealed by clinical and immune characteristics, such as high expression of PD-L1, high tumor mutational burden (TMB-H), Epstein-Barr virus (EBV) positive and CD8

Indexed as

Epstein-Barr Virus InfectionsStomach NeoplasmsHerpesvirus 4, HumanHumansImmunotherapyLymphatic MetastasisLymph Nodesaxillary lymphcase reportEpstein-Barr virusgastric cancerimmunotherapy

Identifiers

PMID38404578
PMCPMC10884146
OpenAlexW4391690863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.